Clinical trials
Productivity clinical trials
Below are recruiting productivity clinical trials, each written for real people, not researchers. We’re tracking 438 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07194733Recruiting
Food as medicine for veterans with kidney disease
This trial tests whether providing healthy food can improve the health of veterans with moderate to severe chronic kidney disease (stages 3b and 4) who are not getting enough nutritious food. If you are a VA patient in the Food Bank of the Rockies area, this study may help you manage your kidney disease.
Aurora, ColoradoAges 18 years+ - NCT07195994Recruiting
Study of an investigational product with or without semaglutide for blood sugar
This trial tests an investigational product to see how well it controls blood sugar in adults with prediabetes or type 2 diabetes. Some participants will also take the diabetes medication semaglutide to compare effects.
London, OntarioAges 18 years+ - NCT07214480Recruiting
Speech therapy for children who struggle with the /s/ sound
This study tests a treatment program for children aged 7 to 11 who have trouble saying the /s/ sound. It's done over Zoom with a computer, and researchers will check if the therapy helps improve their speech.
Syracuse, New YorkAges 7–11 - NCT07236190RecruitingPhase 2
Using brain markers to test NPC-1 for Alzheimer's
This trial tests whether NPC-1, a new drug, can help people with early memory changes or Alzheimer's. Your blood or PET scan will show if you have Alzheimer's-related brain changes, which is required for this study.
Boston, MassachusettsAges 55 years+ - NCT06370273RecruitingPhase 3
Blood thinners for leg casts after injury
This study tests whether taking a blood thinner (anticoagulant) pill can prevent dangerous blood clots in people who have a hard cast or brace on their leg after an injury. It compares two different blood thinners to see which works better.
Carshalton, SurreyAges 16 years+ - NCT04819841RecruitingPhase 1/Phase 2
Gene correction using your own stem cells to improve sickle disease
This trial tests a gene-correction treatment that changes sickle hemoglobin (HbS) into normal hemoglobin (HbA) using your own stem cells. It may help reduce severe sickle cell complications for people with severe disease who meet specific safety and medical criteria.
Los Angeles, CaliforniaAges 12–50 - NCT07266584Recruiting
Retinal implant for central vision loss in inherited eye disease
This trial tests a new implant (PRIMA) placed under the retina to help restore central vision in people with inherited retinal degeneration. If you have very poor central vision and a large enough area of retinal damage, this device may help you see better.
Sydney, New South WalesAges 18 years+ - NCT07290257RecruitingPhase 4
Long-term safety study of Livmarli for Alagille syndrome or PFIC
This study looks at the long-term safety and effects of Livmarli (maralixibat) in children with Alagille syndrome or progressive familial intrahepatic cholestasis (PFIC). It may help understand how well the medicine works over time for itching and other symptoms.
BrusselsAges 2 months+ - NCT07294625RecruitingEarly Phase 1
Gene therapy for relapsed/refractory multiple myeloma
This trial tests a new gene therapy, LVIVO-TaVec200, for people with multiple myeloma that has returned or not responded to other treatments. The goal is to see if it can help control the cancer.
Zhengzhou, HenanAges 18 years+ - NCT07302256RecruitingPhase 1
Flu vaccine trial for adults 60 and older
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
Wuhan, HubeiAges 60 years+ - NCT07318051Recruiting
Sample collection for cancer research study
This study collects blood and tumor tissue samples from patients with certain untreated cancers to help researchers develop and improve tests. You may be eligible if you have one of the listed cancer types and have not yet started treatment.
Austin, TexasAges 18 years+ - NCT07319117Recruiting
Can a nutritional drink help your brain under stress?
This study tests whether a special nutritional drink can help your brain work better when you're under stress. If you're a healthy woman in her 40s or 50s who drinks coffee daily, you may be able to join.
Leeds, West YorkshireAges 40–60 - NCT07322718RecruitingEarly Phase 1
Testing RXIM002 for severe autoimmune diseases
This study tests a new drug called RXIM002 for people with severe autoimmune diseases that haven't improved with standard treatments. It aims to see if targeting immune cells with the CD19 marker can help control the disease.
Shanghai, Huangpu DistrictAges 18–65 - NCT07330856RecruitingPhase 4
Testing treatments for recent dry or productive cough
This trial tests treatments for a recent dry or productive cough caused by a common viral infection like a cold or sore throat. It aims to find options that are safe and effective for adults who are otherwise healthy.
Clermont-FerrandAges 18–65 - NCT07335003Recruiting
Sunscreen study for preventing skin damage in older adults with actinic keratoses
This study tests a new sunscreen (Anthelos Fluide 100 KA+ UVMune 400) to see if it can protect skin and prevent further sun damage in people who already have multiple actinic keratoses (precancerous spots). It may help reduce the risk of new spots or skin cancer.
Camperdown, New South WalesAges 60 years+ - NCT07339605Recruiting
Gum bone regeneration with hyaluronic acid vs enamel matrix
This trial compares two treatments to help regrow bone and gum tissue around teeth with deep bone defects. It tests if hyaluronic acid works as well as enamel matrix derivative, both applied during a minimally invasive procedure.
Valencia, ValenciaAges 18 years+ - NCT07679074Recruiting
Samphire guided care program for women's mood and brain fog
This 12-week program tests a mobile app and gentle brain stimulation device designed to help women manage mood and thinking problems linked to their menstrual cycle, perimenopause, or menopause. It aims to improve day-to-day well-being, work productivity, and overall quality of life.
San Francisco, CaliforniaAges 18–65 - NCT07629115Recruiting
Long-term follow-up study for severe Parkinson's gene therapy
This study follows patients who previously received IPS101A, an experimental gene therapy treatment for severe Parkinson's disease. Researchers want to check how you're doing over time and gather information about the treatment's long-term effects.
SeoulAges 50–80 - NCT07364630RecruitingPhase 4
Placental membrane trial for diabetic and venous leg ulcers
This study tests whether a special wound dressing made from human placental membrane can help heal diabetic foot ulcers or venous leg ulcers that did not close with standard care. It is for people who were in the BIOCAMP trial and whose ulcer remained open after 12 weeks of standard treatment.
Philidelphia, PennsylvaniaAges 18 years+ - NCT07366658RecruitingPhase 1
Experimental therapy for neuroendocrine tumors that did not respond to treatment
This trial tests an experimental therapy (NEUK203-13) for people with neuroendocrine tumors, including small cell lung cancer, that have not responded to or stopped responding to standard treatments. It aims to see if the drug is safe and to look for early signs that it might shrink tumors, especially in people whose tumors have a specific marker called DLL3.
BeijingAges 18–75 - NCT07368959RecruitingPhase 3
New treatment for corneal swelling needing surgery
This trial tests a new treatment for people with corneal swelling that needs surgery. It helps replace the inner layer of the cornea to improve vision.
Mesa, ArizonaAges 18 years+ - NCT07375563RecruitingPhase 3
Chemoimmunotherapy with NK cells for high-risk neuroblastoma
This trial tests a combination of chemotherapy, immunotherapy, and natural killer (NK) cell therapy for children with high-risk neuroblastoma or ganglioneuroblastoma that has not responded to initial treatment or has come back after treatment. The goal is to see if this approach can help destroy cancer cells more effectively.
MoscowAges 1.5 years–18 years - NCT07384676Recruiting
Study on environment and lifestyle in infertility treatment
This study looks at how environmental and lifestyle factors affect infertility and the results of assisted reproductive technology (ART), such as IVF. It aims to help understand what might improve your chances of having a baby.
Changsha, HunanAges 18–46 - NCT07393126Recruiting
A trial of a supplement for mild urinary urgency in healthy Japanese adults
This study tests a product designed to support urinary health. The goal is to see if it helps reduce frequent urination and urgency in healthy Japanese adults who have mild bladder symptoms.
Nerima-ku, TokyoAges 18 years+
Hear when a new Productivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for productivity?
- Yes. Clin2 currently lists 438 recruiting productivity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a productivity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a productivity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.